Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270589
Max Phase: Preclinical
Molecular Formula: C48H71N17O16
Molecular Weight: 1142.20
Associated Items:
ID: ALA5270589
Max Phase: Preclinical
Molecular Formula: C48H71N17O16
Molecular Weight: 1142.20
Associated Items:
Canonical SMILES: CC(=O)N(O)CCC[C@H](NC(=O)[C@H](CCCN(O)C(C)=O)NC(=O)[C@@H](N)CCCN(O)C(C)=O)C(=O)N[C@@H](CCC(=O)NCCNC(=O)CC[C@@H](NC(=O)c1ccc(N(C)Cc2cnc3nc(N)nc(N)c3n2)cc1)C(=O)O)C(=O)O
Standard InChI: InChI=1S/C48H71N17O16/c1-26(66)63(79)21-5-8-32(49)43(72)56-33(9-6-22-64(80)27(2)67)44(73)57-34(10-7-23-65(81)28(3)68)45(74)59-36(47(77)78)16-18-38(70)53-20-19-52-37(69)17-15-35(46(75)76)58-42(71)29-11-13-31(14-12-29)62(4)25-30-24-54-41-39(55-30)40(50)60-48(51)61-41/h11-14,24,32-36,79-81H,5-10,15-23,25,49H2,1-4H3,(H,52,69)(H,53,70)(H,56,72)(H,57,73)(H,58,71)(H,59,74)(H,75,76)(H,77,78)(H4,50,51,54,60,61)/t32-,33-,34-,35+,36-/m0/s1
Standard InChI Key: MKSJTOIGGRJAKW-XLIVJYPCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1142.20 | Molecular Weight (Monoisotopic): 1141.5265 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Rayner B, Verderosa AD, Ferro V, Blaskovich MAT.. (2023) Siderophore conjugates to combat antibiotic-resistant bacteria., 14 (5): [PMID:37252105] [10.1039/d2md00465h] |
Source(1):